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Recent biochemical studies have identified high molecular complexes of the HIV Gag precursor in the cytosol of infected
cells. Using immunoelectron microscopy we studied the time course of the synthesis and assembly of a HIV Gag precursor
protein (pr55gag) in Sf 9 cells infected with recombinant baculovirus expressing the HIV gag gene. We also immunolabeled
for pr55gag human T4 cells acutely or chronically infected with HIV-1. In Sf 9 cells, the time course study showed that the
first Gag protein appeared in the cytoplasm at 28–30 h p.i. and that budding started 6–8 h later. Colloidal gold particles, used
to visualize the Gag protein, were first scattered randomly throughout the cytoplasm, but soon clusters representing 100 to
1000 copies of pr55gag were also observed. By contrast, in cells with budding or released virus-like particles the cytoplasm
was virtually free of gold particles while the released virus-like particles were heavily labeled. Statistical analysis showed that
between 80 and 90% of the gold particles in the cytoplasm were seen as singles, as doublets, or in small groups of up to five
particles probably representing small oligomers. Clusters of gold particles were also observed in acutely infected lympho-
cytes as well as in multinuclear cells of chronically infected cultures of T4 cells. In a few cases small aggregates of gold
particles were found in the nuclei of T4 lymphocytes. These observations suggest that the Gag polyprotein forms small
oligomers in the cytoplasm of expressing cells but that assembly into multimeric complexes takes place predominantly at thedegradation. © 2002 Elsevier Science (USA)
INTRODUCTION
The assembly of retroviruses offers an attractive target
for the development of anti-viral agents but requires
detailed knowledge of the assembly pathway and of the
intermediates involved. To date most information con-
cerning retroviral assembly has come from biochemical
and molecular biological studies (reviewed in Kra¨usslich,
1996; Weldon and Hunter, 1997; Jones and Morikawa,
1998; Freed, 1998; Garnier et al., 1998) and has concen-
trated on identification of the interacting sequences. Lit-
tle is known about the assembly pathway and the cellu-
lar sites at which it begins.
The major retroviral structural protein, pr55gag, which
forms a submembrane shell in immature virus particles,
is synthesized on free ribosomes (Eisenman and Vogt,
1978). Electron microscopy studies have provided evi-
dence that this protein assembles into regular arrays at
the inner surface of the plasma membrane before or
concomitant with the process of budding (Nermut et al.,
1994, 1998). This is the first stage in the formation of an
1 To whom correspondence and reprint requests should be ad-
dressed at The National Institute for Biological Standards and Control,219immature Gag shell. Incorporation of viral glycoproteins
gp120/41 and the enzymatic proteins completes the as-
sembly process.
Biochemical studies have shown the presence of mul-
timeric assemblies in the cytoplasm of human immuno-
deficiency virus (HIV)-infected cells. Spearman et al.
(1997) reported the presence of dimers, trimers, and
multimers of HIV p17gag (MA) both in the cytosol and in
the membrane fraction of infected cells. Lee and Yu
(1998) described a “detergent-resistant” HIV gag protein
complex in the supernatant of Nonidet-lysed cells as
opposed to a “detergent-sensitive” Gag protein associ-
ated with cellular membranes. Lee et al. (1999) purified
the detergent-resistant complex and showed that it could
be disrupted by high salt treatment. The presence of HIV
Gag oligomers in solution was reported by Scarlata et al.
(1998). HIV MA trimers in solution were reported by
Morikawa et al. (1998) and large Gag complexes (about
1000 kDa) were found in the cytosol of Spodoptera fru-
giperda (Sf 9) cells infected with a recombinant baculo-
virus expressing HIV pr55gag by Morikawa et al. (2000).
A recent study by Wang et al. (2001) showed that dele-
tions within the MA domain resulted in the formation of
assembly intermediates in the cytoplasm and buddingplasma membrane. Large accumulations of Gag protein in
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Blanc et al. (2002), who found that the wild-type (wt)
Human T-cell leukemia virus (HTLV) Gag protein does
not bind to cytoplasmic vesicles, but is free in the cytosol
and is seen in the form of punctate fluorescence, which
they concluded indicated that HTLV Gag protein assem-
bly starts in the cytoplasm. The precise oligomeric state
of the Gag polyprotein in the cytoplasm, the mechanism
of transport of Gag molecules to the plasma membrane,
and the site of the first steps in the assembly of immature
Gag shells have not been resolved by the above studies.
Interestingly, pulse/chase experiments (Tritel and Resh,
2000; M. Suomalainen, personal communication) have
provided evidence for the fast transport of newly synthe-
sized HIV Gag to the plasma membrane.
Previous observations of clusters of Gag protein in the
cytoplasm of HIV-infected cells by immunoelectron mi-
croscopy (unpublished results) stimulated us to study the
time course of Gag protein synthesis and assembly in
HIV-infected cells with the aim of confirming or refuting
the notion that Gag protein assembly starts in the cyto-
plasm of expressing cells. Unlike biochemical analyses,
immunoelectron microscopy has the benefit of determin-
ing the topography and distribution of the protein in the
cytoplasm at different stages of the infectious process.
Initially, we took advantage of the high levels of HIV gag
protein expressed by recombinant baculovirus-infected
cells, as this allowed easy evaluation of the results of
time course labeling. In addition, acutely or chronically
HIV-infected T4 lymphocytes were also studied. The re-
sults provided evidence that only a limited degree of Gag
oligomerization takes place in both cellular systems in
the cytoplasm. It thus appears that multimeric prebud-
ding complexes assemble predominantly at the plasma
membrane.
RESULTS
The time course of Gag protein assembly in
recombinant baculovirus-infected Sf 9 cells
No immunolabeling for Gag antigen was observed in
infected Sf 9 cells prior to 24 h p.i., consistent with the
known temporal pattern of polyhedrin promoter-driven
transcripts (O’Reilly et al., 1992). However, gold particles
were observed after 28–30 h p.i., first close to the nuclear
membrane and later scattered throughout the cytoplasm
mainly in ribosome-rich areas (Fig. 1a). In a few cases,
however, an accumulation of gold particles was also
observed over dense areas free of ribosomes. The num-
ber of gold particles increased substantially between 34
and 36 h p.i. During this period a common feature was
single gold particles, doublets, or only small groups (3–5
gold particles) in the cytoplasm of many cells. Groups of
10 to 70 gold particles were regularly observed (Figs. 1b
and 1c), but very large accumulations (up to 200 gold
particles) were rare (Fig. 2). In most cases gold aggre-
gates were associated with a dark background, indicat-
ing the presence of proteinaceous material (Figs. 1b–1d).
Most gold clusters were larger in diameter than average-
size virus particles (about 130 nm).
We classified the counted gold particles in Sf 9 cells
into five categories: single particles, doublets, 3 to 5
particles, 6 to 10 particles, and over 10 particles. This
evaluation was done in cells at 30, 32, 34, 36, and 44 h
p.i. The great majority of gold particles was small groups
of up to 5 gold particles (from 80 to 90%), while the
number of colloidal gold clusters in the over-10 category
was small and heterogeneous in size (from 4 to 15%).
Clusters containing very large numbers of gold particles
also biased the total number of gold particles in that
category (Figs. 1b–1d and 2). Despite the high m.o.i.
used during infection, synchronous expression of Gag
protein was not achieved. Some cells produced virus-like
particles (VLP) after 36 h p.i., while the majority of cells
reached the state of VLP budding and release at about
40 to 44 h p.i. At this time point the cytoplasm was
virtually free of gold particles and only a few gold parti-
cles were associated with the plasma membrane, while
free VLP were heavily labeled (Fig. 1e).
Gold immunolabeling of Gag protein in T4
lymphocytes
As the levels of Gag antigen synthesis using the re-
combinant baculovirus system were high, it was possible
that Gag protein accumulation within the cell could be
simply the consequence of abnormally high protein con-
centrations. To verify that this was not the case, a study
of Gag protein expression in acute and chronic infection
of lymphocytes was undertaken. In keeping with the
altered replication kinetics, the time scale of Gag expres-
sion was much longer than that in Sf 9 cells, with the first
budding observed after 2 or 3 days depending on the
m.o.i. used. Similarly, the number of gold particles in the
cytoplasm was substantially lower than that in the bac-
ulovirus system; however, distinct clusters of colloidal
gold were observed both deep in the cytoplasm and
close to the cell surface (Figs. 3a and 3b) together with
a low number of single gold particles. The low level of
labeling prevented a statistical evaluation of the gold
particle distribution in acutely infected T4 cells. In a few
cases small groups of gold particles were also observed
in nuclei in both the C8166 and the CEM cells (Fig. 3c).
Chronically infected JM cells provided further evidence
for the presence of Gag protein aggregates in the cyto-
plasm. In multinuclear syncytia small or large groups of
gold particles either mixed with ribosomes or more fre-
quently associated with small, occasionally large, dense
areas of irregular shape were observed (Fig. 4a). The
number of gold particles in such clusters varied from a
few to about 20, representing up to 100 copies of the Gag
precursor (see below). By comparison, the average num-
ber of gold particles per section of a released virus
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particle was 13.7 (SD 4.4, N  64). Very large clusters of
gold particles such as those observed in Sf 9 cells were
not seen. The surface area covered by gold clusters in
the cytoplasm varied from 1000 to over 10,000 nm2, while
the area of virus particles was about 1000 nm2. Single
cells were usually free of gold particles. Some syncytia
FIG. 1. Sf 9 cells after immunolabeling with monoclonal antibody for p55/24 and 5-nm colloidal gold. (a) Gold particles are scattered throughout the
cytoplasm of Sf 9 cells 30 h after infection with recombinant baculovirus-expressing HIV p46gag. Some doublets of gold particles are circled. (b) Aggregates
of colloidal gold particles in Sf 9 cells 36 h p.i. and (c) 32 h p.i. (d) Large group of colloidal gold particles associated with a homogenous high-electron-
density area in Sf 9 cell 34 h p.i. (e) Sf 9 cell 44 h p.i. with released VLP. Note very low density of gold particles in the cytoplasm. Bars, 100 nm.
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contained only a few gold particles in the cytoplasm, but
in such cases large numbers of free virus particles were
observed close to the cell surface, often between the
microvilli, and also budding into large syncytial vesicles
filled with virus particles (Fig. 4b). Occasionally, such
large vesicles contained clusters of gold particles of
various shapes not typical of virus particles (Fig. 4c). The
distribution of gold particles in multinuclear cells (Fig. 2)
revealed differences when compared with the distribu-
tion of Gag molecules in Sf 9 cells. Specifically, the pro-
portion of small groups of 1 to 5 gold particles was lower
in chronically infected cells (50%) than in Sf 9 cells, re-
flecting the level of Gag expression achieved by each
system. On the other hand, the number of gold particles
in the category of over 10 was only 28.5%, and there were
21.5% gold particles in the category of 6–10. Some giant
cells were in an early stage of virus production (see
above), while others were surrounded by masses of free
virus particles (VP) heavily labeled with antibody to HIV
p24.
DISCUSSION
Investigation of retroviral Gag protein synthesis and
assembly has, so far, largely concerned biochemical and
molecular biology approaches. While this approach has
provided much information concerning the fate of Gag
protein en masse, the pathway of assembly at the indi-
vidual cell level has been harder to define. We have used
immunoelectron microscopy to visualize the presence of
Gag protein in the cytoplasm of expressing cells within a
period from synthesis to release of immature virus-like
particles or wt viruses. The aim of this study has been to
contribute to the discussion of the initial site of Gag
protein assembly (i.e., early multimerization): in the cyto-
plasm or exclusively at the plasma membrane. Answer-
ing these questions will improve our knowledge of the
process of the assembly of HIV and may have parallels
for other budding viruses.
FIG. 3. Clusters of gold particles found below plasma membrane (a)
or deep in cytoplasm (b) of acutely HIV-1-infected C8166 cells (48 h p.i.).
Single gold particles were very rare in this cell. (c) A small group of gold
particles in a nucleus of an acutely infected C8166 cell. Arrowheads point
to plasma membrane in (a) and to nuclear membrane in (c). Bars, 100 nm.
FIG. 2. (Left) Distribution of HIV gag molecules in Sf 9 cells at
different times p.i. A, Groups of 1–5 gold particles. B, Groups of 6 to 10
gold particles. C, Groups of more than 10 gold particles. Total counts of
gold particles in cells 30 h p.i.  2360; 32 h p.i.  1935; 34 h p.i.  959;
36 h p.i.  3570; 44 h p.i.  1616. An efficiency of 20% was used to
calculate the number of Gag copies. Category 1 to 5 gold particles may
represent small Gag oligomers (dimers or trimers), category 6 to 10
gold particles may represent small assemblies of dimers or trimers,
category over-10 gold particles may represent multimers or aggregates
of Gag protein. (Right) Distribution of HIV Gag molecules in chronically
infected JM cells. A, Groups of 1–5 gold particles. B, Groups of 6–10
gold particles. C, Groups of more than 10 gold particles. Gold particle
counts in A  3160, B  1360, C  1800.
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Distribution of colloidal gold particles in the cytosol
and calculation of the number of corresponding Gag
molecules
Colloidal gold immunolabeling of thin sections of Sf 9
cells infected with a recombinant baculoviruses express-
ing Pr46gag provided convincing evidence for the pres-
ence of Gag molecules in the cytoplasm. These findings
correlate well with biochemical studies reporting the
presence of dimers, trimers, or small oligomers in solu-
tion (Spearman et al., 1997; Scarlata et al., 1998;
Morikawa et al., 1998) and large accumulations of Gag in
the cytosol (Lee and Yu, 1998; Lee et al., 1999; Morikawa
et al., 2000). However, the distribution of colloidal gold
FIG. 4. (a) The cytoplasm of a multinuclear cell of chronically infected JM cells with groups of about 20 gold particles situated above dense
cytoplasmic structures (arrowheads) or scattered in the cytoplasm (arrow). (b) Virus particles released into a large vacuole. Arrows point to a
hemispherical structure, probably a budding virus particle. (c) Large vacuole filled with gold particles either single or in clusters of varying sizes and
shapes. Bars, 100 nm.
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particles (Fig. 2) showed clearly that the majority of Gag
molecules (about 80 to 90%) was found in small groups
of up to 10 gold particles. To convert these figures into
numbers of Gag protein molecules requires the knowl-
edge of the immunolabeling efficiency in our experimen-
tal conditions, the value of which depends on the quality
of the antibodies used, the accessibility and preservation
of the specific epitope, and the preparative techniques.
Generally, the efficiency of gold immunolabeling for elec-
tron microscopy has been estimated at 1–10% (Griffiths,
1993), but this can be higher when labeling cell surface
antigens (Nermut and Nicol, 1989; Erlandsen et al., 2001).
Using the procedure described under Materials and
Methods, we concluded that the efficiency in our exper-
imental conditions was about 20%. This efficiency factor
would indicate that most Gag molecules in the cyto-
plasm existed as relatively small oligomers of tens of
Gag copies. Accordingly, gross multimerization of Gag
into 2D sheets, which then induce the curvature typical of
early budding, takes place predominantly at the plasma
membrane. It is interesting to note that variation in label-
ing efficiency from 17 to 27% (the credible range of
values that could be applied using known Gag and virus
dimensions) would not substantially alter these conclu-
sions. While the number of large clusters of gold parti-
cles was small when compared with the number of small
groups, the overall number of Gag molecules in the
aggregates was substantially larger (from a few dozens
to hundreds of gold particles, see Figs. 1b–1d and 2).
This discontinuity of size class, the sporadic occurrence,
and the relative Gag content suggest that large Gag
complexes are not part of the normal pathway of assem-
bly and may represent misfolded Gag that fails to enter
the assembly pathway and is destined for degradation. It
has been reported that up to 80% of Gag may be de-
graded by proteasomes because of misfolding (Schubert
et al., 2000; Tritel and Resh, 2000). Based on the numbers
of large aggregates observed, our data suggest that at
least 20% of Gag molecules might be destined for deg-
radation in Sf 9 cells, although the exact proportion
would probably depend on the type and physiological
state of the expressing cell.
Are cytoplasmic Gag oligomers the first stages of
organized virus assembly?
Our study confirms the previous findings of Gag in
the cytosol of HIV-infected cells (Lee and Yu, 1998; Lee
et al., 1999; Morikawa et al., 2000). Extending the
above reports we made an attempt to determine the
size of the Gag oligomers by classifying gold particles
observed in the cytoplasm into groups of up to 10 gold
particles and above. Our data showed that a great
majority of Gag molecules exist as small assemblies
(Fig. 2). Since Gag is synthesized on free ribosomes
(Eisenman and Vogt, 1978) and released into an aque-
ous environment, self-association into dimers, trimers,
or oligomers will take place when a critical concen-
tration of protein is reached, aided by hydrophobic
residues on the protein surface (Matthews et al., 1994;
Hill et al., 1996) and the formation of hydrogen bonds
(see Turner and Summers, 1999, and refs. therein).
Electrostatic interactions between charged groups on
MA (Hill et al., 1996; Forster et al., 2000) may also
enhance the probability of limited protein oligomeriza-
tion in the cytosol. Trimers or multimers of MA have
been observed in cell lysates of Gag-expressing cells
(Scarlata et al., 1998; Morikawa et al., 1998), but no
electron microscopy of the larger Gag protein com-
plexes observed by Lee et al. (1999) has been reported
to date. However, our examination by electron micros-
copy of the high-molecular-weight Gag aggregates
reported by Morikawa et al. (2000) has failed to reveal
any regular structural complexes (M.V. Nermut, unpub-
lished data), consistent with their probable identifica-
tion as misfolded and aggregated material.
Thus, while small Gag assemblies are formed in the
cytosol, we conclude that the formation of ordered
higher molecular weight complexes (2D sheets and
spherical capsids) takes place only after association
of Gag with the inner surface of the plasma mem-
brane. This conclusion is supported by subcellular
fractionation (Tritel and Resh, 2000) and, in particular,
by confocal imaging, which has shown the presence of
Gag in the plasma membranes (and in cellular vesi-
cles) of infected cells (Hermida-Matsumoto and Resh,
2000). Our previous electron microscopy study re-
vealed small patches, as well as occasionally large,
triangular 2D sheets of Gag protein on the protoplas-
mic surface of the plasma membrane of Sf 9 cells
(Nermut et al., 1994, 1998). This does not rule out
formation of spherical or part-spherical Gag shells in
the cytoplasm under specific conditions. For example,
high concentrations of HIV Gag in Sf 9 cells producing
a C-terminal truncation mutant of Gag showed pre-
formed Gag shells free in the cytoplasm or budding
into cytoplasmic vacuoles (see Fig. 4 in Hockley et al.,
1994). Recently, Wang et al. (2001) reported that dele-
tion of all but the first 15 MA residues resulted in the
formation of intracellular virus particles and concluded
that wild type Gag–Gag interactions occur initially in
the cytoplasm to form “assembly intermediates” which
subsequently interact with plasma membrane and cel-
lular vesicles. This conclusion may be premature, as
the 10 groups of gold particles observed in our study
showed neither the typical structural features nor the
right diameter to be qualified as virus particles. Also,
the number of gold particles was, in most cases, larger
than the average of 15 gold particles per immature or
mature virus particle (see above).
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Kinetics of the assembly process
Our observations suggested a 6- to 8-h period be-
tween initial Gag synthesis and the assembly of VLP. A
similar delay (4–6 h after pulse) was observed in the
experimental conditions used by Tritel and Resh (2000)
and Morikawa et al. (2000). Slow transport of Gag is
unlikely, since the results of pulse/chase experiments
have revealed that a subpopulation of Gag protein
reaches the plasma membrane within 5–10 min (Tritel
and Resh, 2000; M. Suomalainen, personal communica-
tion).
Interestingly, budding from individual cells started ap-
proximately in synchrony in keeping with the accumula-
tion of a critical minimum of small oligomers before
arrangement into the periodic 2D assemblies destined to
form spherical Gag shells (Nermut et al., 1998). This
notion is supported by the observation that the high
number of gold particles observed in the cytoplasm for
several hours reduces rather quickly approximately 1 h
or more before the start of budding. The requirement to
diffuse within lipid bilayers to lipid rafts, the presumed
site of final assembly (Nguyen and Hildreth, 2000; Ono
and Freed, 2001), and/or the incorporation of envelope
glycoproteins might also provide a barrier to the budding
and release process which is suddenly overcome when
a critical concentration is reached. Lastly, the experimen-
tal system we have used to generate significant levels of
Gag in order to follow its routing, recombinant baculovi-
ruses, is a transient system in which a “wave” of Gag
synthesis is followed by cell senescence. This may, itself,
enforce a degree of synchrony.
Specific situation in multinuclear cells
The image in chronically infected mammalian cells
differed from that seen in Sf 9 cells in respect to the
lower density of gold particles in the cytoplasm and also
to the size of the gold aggregates (Fig. 2). There were
substantially less gold particles in the 1–10 class in
chronically infected cells. On the other hand, the propor-
tion of clusters containing more than 10 gold particles
was higher than in Sf 9 cells. No data concerning the
proportion of degraded Gag in chronically infected cells
have been published, but assuming that the interpreta-
tion of the dark background to gold clusters as sites of
degradation is correct, our observations would suggest
that Gag digestion takes place both in the cytoplasm
(Fig. 4a) and also in some large “syncytial vesicles” (Fig.
4c) possibly equivalent to secondary lysosomes or mul-
tivesicular bodies. Other large vesicles contained numer-
ous virus particles (Fig. 4b). There is an uncertainty about
the nature of round or oval large structures (occasionally
labeled with anti-CA antibody) reminiscent of cellular
vesicles (Fig. 4a). The medium used for low-temperature
embedding does not visualize vesicular structures well
enough to enable their identification, but as a whole our
observations are in line with reports by Grief et al. (1991)
and others (reviewed in Harris, 1993), which showed that
the major producers of the virus were multinuclear cells,
while single cells were mostly free of signs of assembly
or budding. No immunolabeling for Gag was done in the
above papers, limiting our ability to make direct compar-
isons.
In conclusion
Our observations have shown that (1) there is a long
delay between the start of synthesis, budding, and re-
lease of immature virus particles (such delay might indi-
cate a limited efficiency of the “synthesis engine” and
also that the organization of Gag oligomers into periodic
structures at the plasma membrane is a slow process);
(2) in the “intermediate period” (from 30 to about 40 h p.i.)
the cytoplasm is predominantly filled with small Gag
assemblies, which suggests that the process of Gag
assembly into 2D and 3D structures takes place at the
plasma membrane, in agreement with previously pub-
lished electron microscopy observations; and (3) the
presence of large aggregates of gold particles in the
cytoplasm during the intermediate period is consistent
with findings that a large proportion of newly synthesized
Gag is degraded.
MATERIALS AND METHODS
Spodoptera frugiperda cells were infected with recom-
binant baculoviruses expressing truncated HIV Gag pre-
cursor (p46gag, Jowett et al., 1992) at an m.o.i. of about 5
and grown at 27°C in liquid TC 100 medium supple-
mented with 10% fetal bovine serum. Cells were har-
vested at 24, 28, 30, 32, 34, 36, 44, and 48 h postinfection
and fixed in 3% paraformaldehyde for several hours. The
cells were washed in phosphate-buffered saline (PBS)
and processed for low-temperature embedding in Lowi-
cryl HM20 using the routine “progressive lowering of
temperature” protocol.
Human T4 (C8166) cells were infected with HIV-1 (RF)
and processed after 2 days for low-temperature embed-
ding after freeze-substitution (see below). In addition,
CEM SS cells were also infected with HIV-1 (strain LAV)
and immunolabeled 3, 6, 9, and 10 days later. In a study
of chronic infection, JM cells (NIBSC Repository, ARP
008) were infected with HIV-1, strain GB8 (ARP 131.1), and
processed as follows: Cells were fixed in 3% paraformal-
dehyde overnight, washed in PBS, and embedded in 1.5%
agarose. The cell pellet solidified in agarose was cut into
small pieces which were equilibrated in 2.3 M sucrose
overnight. Small pieces of agarose-embedded cells were
rapidly frozen in liquid ethane and freeze-substituted in
absolute methanol with 0.5% uranyl acetate (Grief et al.,




Thin sections were preconditioned in Tris-buffered sa-
line (TBS), pH 8.2, containing 0.1% bovine serum albumin
(BSA-C, Aurion, Netherlands) and 0.1% fish gelatine (Bio-
Cell International, Cardiff, UK) followed by monoclonal
antibody to p55/24 (ARP 313) diluted 300 with the
above buffer (TBG). Control grids were incubated in TBS
or in a nonspecific monoclonal antibody. After 60 min at
room temperature, grids were washed 3 for 5 min each
in TBG, followed by incubation for 45 min in 10 diluted
gold anti-mouse antibody conjugated to 5-nm colloidal
gold (Bio-Cell). After three washes in TBG, followed by
TBS and distilled water, sections were stained in alco-
holic uranyl acetate for 8 to 10 min. Carbon-coated sec-
tions were examined in a Philips CM12 electron micro-
scope operated at 80 kV. The surface area of virus
particles or colloidal gold clusters was measured using
a Kontron Digiplan magnetic tablet.
For calculating gold immunolabeling efficiency in low-
temperature-embedded sections, we counted colloidal
gold particles associated with VLP produced in Sf 9 cells
and also with virus particles observed in chronically
infected lymphocytes. The obtained average figures
were related to the number of Gag protein molecules
supposedly exposed in cross-sectioned VLP or VP. In
immature virus particles such as VLP, the Gag polypro-
tein forms a radial palisade of Gag molecules with the
major CA domain well exposed to specific antibodies.
We calculated the number of exposed CA domains in a
spherical shell 120 nm in diameter by dividing its circum-
ference by 5 nm, which is an average spacing between
Gag molecules in frozen hydrated HIV VLP (5.5 nm by
Fuller et al., 1997) and murine leukemia virus immature
particles (4.5 nm by Yeager et al., 1998). The counts of
gold particles from sections of VLP (Sf 9 cells) provided
an average of 17.7 (STD 9.1, N 51) and 13.75 (STD 4.4, N
64) of wt HIV particles from chronically infected T4 cells.
This difference is understandable, since the VLP Gag
shell is of immature form, while, in HIV virions, the con-
densed core provides a smaller surface area for antibody
binding. For practical reasons we amalgamated the
above data, which resulted in a mean of 15.5 (SD 6.2,
N  115). The immunolabeling efficiency based on
those figures was 24% for 100-nm-wide virus particles
and 20% for 120-nm-wide particles. We used the more
conservative 20% in our estimates of Gag molecules
represented by a single gold particle.
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